Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia

MLA

Noh, Hayeon, et al. “Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia.” Blood, vol. 128, no. 22, Dec. 2016, p. 3086. EBSCOhost, https://doi.org/10.1182/blood.V128.22.3086.3086.

APA

Noh, H., Jung, S. Y., Kwak, J.-Y., Kim, S.-H., Oh, S. J., Zang, D. Y., Park, H. L., Jo, D. J., Shin, J. S., Do, Y. R., Kim, D.-W., & Lee, J. I. (2016). Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia. Blood, 128(22), 3086. https://doi.org/10.1182/blood.V128.22.3086.3086

Chicago

Noh, Hayeon, Su Young Jung, Jae-Yong Kwak, Sung-Hyun Kim, Suk Joong Oh, Dae Young Zang, Hye Lin Park, et al. 2016. “Impact of Body Weight Adjusted Dose on Efficacy and Safety of Radotinib in Chronic Myeloid Leukemia.” Blood 128 (22): 3086. doi:10.1182/blood.V128.22.3086.3086.